Development of a novel dengue virus serotype-specific multiplex real-time reverse transcription-polymerase chain reaction assay for blood screening.
Development of a novel dengue virus serotype-specific multiplex real-time reverse transcription-polymerase chain reaction assay for blood screening.
复制标题
开发一种用于血液筛查的新型登革热病毒血清型特异性多重实时逆转录聚合酶链反应测定法。
DOI:
10.1111/trf.13875
复制
发表时间:
2016
期刊:
影响因子:
2.9
通讯作者:
and Isao Hamaguchi
中科院分区:
文献类型:
--
作者:
Kenta Tezuka;Madoka Kuramitsu;Kazu Okuma;Kiyoko Nojima;Kumiko Araki;Naoya Shinohara;Chieko Matsumoto;Masahiro Satake;Tomohiko Takasaki;Masayuki Saijo;Ichiro Kurane;and Isao Hamaguchi
BACKGROUNDDengue fever is caused by four related RNA viruses of the genusFlavivirus, dengue virus (DENV)‐1, ‐2, ‐3, and ‐4, which are transmitted to humans by mosquitoes. Although DENV is not endemic in Japan, an autochthonous dengue outbreak occurred in 2014. Several transfusion‐transmitted cases have also been reported after the use of blood and plasma products in DENV‐endemic countries. The aim of this study was to develop a novel multiplex reverse transcription–polymerase chain reaction (RT‐PCR) assay for DENV blood screening.STUDY DESIGN AND METHODSLarge‐scale oligonucleotide screening was performed to obtain DENV‐specific primers and probes using a variety of DENV clinical isolates. A multiplex RT‐PCR assay was then developed using the identified oligonucleotides and the ability of this assay to detect DENV RNA was evaluated.RESULTSA number of oligonucleotides suitable for DENV RNA detection were identified and a novel DENV serotype‐specific multiplex RT‐PCR assay was successfully established. Comparative analysis revealed that the multiplex assay could detect levels of viral contamination as low as 100 viral copies/mL.CONCLUSIONThis established serotype‐specific multiplex RT‐PCR assay provides a simple, sensitive, and quantitative detection method for DENV, which could be applied in the screening of blood samples to prevent transfusion‐transmitted DENV infection.